Introduction to AHK-Cu 200mg (Copper Tripeptide)

AHK-Cu, biochemically categorized as a copper-complexed tripeptide ($\text{L-Alanyl-L-histidyl-L-lysine-Cu}^{2+}$), is a highly stable molecular probe engineered for high-resolution topical and cutaneous research models. Structurally optimized with a high-affinity divalent copper ion, the AHK-Cu sequence serves as a specific vehicle designed to evaluate localized tissue restructuring, endothelial cell stabilization, and follicular growth dynamics within mammalian skin models.

Because large macro-proteins face significant transport barriers when interacting with the stratum corneum and outer root sheath architectures, AHK-Cu’s minimized three-amino-acid structure makes it an ideal candidate for tracking cell-autonomous signaling pathways within localized matrices. At USA PEPTIDE SCIENCES, we supply this high-concentration configuration as a vacuum-sealed, lyophilized 200mg vial, providing dermatology, molecular biology, and regenerative medicine laboratories with an ultra-pure, standardized reagent to map follicular proliferation curves and structural remodeling kinetics.

Research Overview: Follicular Proliferation and Copper-Dependent Dermal Restructuring

The primary scientific value of AHK-Cu 200mg centers on its capacity to modulate local cellular survival cascades and genetic transcription lines linked to hair follicle development and dermal resilience. By focusing on non-systemic, localized interfaces, this copper peptide complex allows researchers to analyze structural cellular dynamics under controlled laboratory conditions.

Key areas of active scientific investigation utilizing AHK-Cu 200mg include:

• Dermal Papilla Cell Viability and Follicular Extension: Modeling the elongation of hair follicles. Dermal papilla cells (DPCs) are specialized mesenchymal cells at the base of the hair follicle that regulate hair cycle transitions and fiber growth. Researchers utilize AHK-Cu to evaluate the suppression of apoptotic (programmed cell death) loops in DPCs, monitoring how the peptide complex influences the maintenance of the active growth (anagen) phase in animal models.

• Vascular Endothelial Growth Factor (VEGF) Upregulation: Investigating microvascular density surrounding localized tissue structures. Follicular development and active wound closure rely on an adequate supply of oxygen and nutrients. Investigators analyze AHK-Cu’s capacity to stimulate the localized expression of vascular endothelial growth factor (VEGF), mapping the subsequent formation of new capillary branches around treated areas.

• Extracellular Matrix (ECM) Overhaul and Collagen Overexpression: Analyzing the deposition of structural proteins within the dermis. Researchers track the downstream impact of AHK-Cu on upregulating Type I collagen synthesis and optimizing matrix metalloproteinase (MMP) ratios. Studies focus on establishing how the copper complex balances healthy structural integrity while discouraging disorganized, fibrotic scar accumulation during tissue restoration trials.

• Transforming Growth Factor Beta (TGF-$\beta$) Cascade Modulation: Evaluating the suppression of inhibitory signaling pathways. Members of the TGF-$\beta$ family often act as primary triggers for catagen (involution) phase entry and localized follicle regression. Investigators utilize AHK-Cu to track downregulations in these inhibitory cascades, evaluating its role in maintaining stable, uncorrupted cellular replication lines.

Quality Standards & Analytical Testing

At USA PEPTIDE SCIENCES, laboratory data integrity and compound reproducibility are the fundamental core of our manufacturing operations. Every single production lot of AHK-Cu 200mg (Topical) undergoes a severe quality control validation protocol to eliminate compounding variables and experimental artifacts. We utilize High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm an absolute chemical purity profile of 99% or greater. This rigorous analytical validation verifies the exact tripeptide sequence composition (Ala-His-Lys), precise copper coordination stoichiometry, correct molecular weight, and correct spatial conformation while ensuring the total absence of residual synthesis reagents, truncated fragments, heavy metals, or raw contaminants. A batch-specific Certificate of Analysis (COA) accompanies every order to guarantee absolute reproducibility.

Storage and Handling Requirements

To safeguard the complex molecular bonds and prevent premature thermal or mechanical breakdown of the 200mg lyophilized cake, all vials must be stored long-term in a freezer environment at -20°C, completely shielded from light and ambient moisture. Prior to introducing the compound into your laboratory workflow, reconstitution must be carried out using an appropriate sterile, non-pyrogenic, or bacteriostatic diluent optimized for topical or localized cellular applications. Once transitioned into a liquid state, the peptide solution becomes highly sensitive to thermal breakdown and mechanical stress; reconstituted vials must be maintained under constant refrigeration at 2°C to 8°C. Researchers must dissolve the compound via a slow, gentle swirling motion, avoiding any aggressive mechanical agitation, inversion, or shaking.

Research Use Disclaimer

The compounds distributed by USA PEPTIDE SCIENCES, including AHK-Cu 200mg research vials, are designated strictly for laboratory research purposes only. Under no circumstances are these products approved or intended for human or veterinary consumption, direct clinical diagnostics, or therapeutic drug administration. All handling, measuring, and experimental evaluation must be conducted exclusively by qualified scientific professionals within a certified and monitored research facility.